RxSight Overview
RxSight Target Price
Analysts' average 12-month price target for RxSight is $7.5.
Get informed when a big investor buys or sells
+ FollowShare Price
$7.03
Average Target Price
$7.50
6.7% upside
6.7% upside4 analysts in the last 4 months
High: $11 | Low: $5.5
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-10 | Stifel Nicolaus | $7 |  0.4% downside |  |
| 2026-07-28 | UBS | $5.5 | 21.8% downside | |
| 2026-07-07 | Jefferies | $6.5 | 7.5% downside | |
| 2026-05-07 | Needham | $11 | 56.5% upside | |
| 2026-03-09 | Stifel NicolausThomas Stephan | $9 | 28% upside | |
| 2026-02-26 | NeedhamDavid Saxon | $13 | 84.9% upside | |
| 2026-01-20 | Piper Sandler | $11 | 56.5% upside | |
| 2025-12-02 | Morgan Stanley | $10 | 42.2% upside | |
| 2025-11-06 | Stifel Nicolaus | $10 | 42.2% upside | |
| 2024-10-29 | BarclaysAdam Seiden | $110 | 1464.7% upside | |
| 2024-10-29 | GuggenheimCurry Baker | $52 | 639.7% upside | |
| 2024-10-29 | Mizuho SecuritiesAnthony Crowdell | $67 | 853.1% upside | |
| 2024-10-29 | JefferiesYoung Li | $72 | 924.2% upside | |
| 2024-09-23 | BTIGRyan Zimmerman | $59 | 739.3% upside | |
| 2024-09-13 | NeedhamDavid Saxon | $66 | 838.8% upside | |
| 2024-08-06 | Stifel NicolausThomas Stephan | $65 | 824.6% upside | |
| 2024-08-06 | NeedhamDavid Saxon | $54 | 668.1% upside | |
| 2024-05-07 | OppenheimerSteven Lichtman | $72 | 924.2% upside | |
| 2024-05-07 | NeedhamDavid Saxon | $75 | 966.9% upside | |
| 2024-05-07 | Stifel NicolausTom Stephan | $75 | 966.9% upside | |
| 2024-05-07 | Wells FargoLawrence Biegelsen | $68 | 867.3% upside | |
| 2024-05-07 | BTIGRyan Zimmerman | $72 | 924.2% upside | |
| 2024-05-06 | Stifel NicolausThomas Stephan | $68 | 867.3% upside | |
| 2023-12-13 | Wells FargoLawrence Biegelsen | $42 | 497.4% upside | |
| 2023-07-12 | NeedhamDavid Saxon | $34 | 383.6% upside | |